Lactate/Albumin Ratio as a predictor of Mortality In advanced liver Cirrhosis in Egyptian Patients

Document Type : Original Article

Authors

1 Internal Medicine Department, Faculty of Medicine, Zagazig University

2 Clinical Pathology, Faculty of Medicine, Zagazig University

Abstract

Background: The lactate/albumin ratio can be used as an early prognostic indicator in hepatic patients, according to several studies. In order to forecast adverse events in the context of hepatic decompensation, it became necessary to determine the clinical importance and offer fresh perspectives on the predictive usefulness of these straightforward and easily accessible regular serum indicators. Therefore, our goal was to determine whether the increased lactate/albumin ratio might be used to predict in-hospital mortality in patients with cirrhosis who were admitted to the hospital.

Methods: This prospective study was conducted on 60 cirrhotic patients who attended the Intensive Care Unit (ICU) in the Internal Medicine Department at Zagazig University Hospital, Egypt. Lactate/Albumin Ratio was measured in all cases.

Results: Lactate /Albumin that were significantly higher in death group than alive group. At a cut off 1.2, lactate/albumin showed AUC=0.795 with sensitivity 58.1%, 94.9% specificity and p value 0.003 in prediction of death among advanced liver cirrhotic patients.

Conclusion: Lactate/albumin ratio is a promising and easily accessible biomarker for predicting the mortality of individuals with decompensated cirrhosis. Regarding the in-hospital mortality of decompensated cirrhotic patients, the lactate/albumin ratio is considered a useful biomarker for outcome prediction.

Keywords

Main Subjects

Zagazig University Medical Journal
Volume 31, Issue 4
April 2025
Pages 1617-1624

Files

Share

How to cite

Statistics